Developer docs
API playgroundTry for free, no card

Search company profiles

Auspep

Full company profile

uuid002v4ut

Namestring
Auspep
Legal namestring
Auspep
Websiteurl
auspep.com.au
Company typeenum
Private
Founded yearint
1987
Descriptiontext

Auspep is an Australian specialty manufacturer of synthetic peptides, founded in 1987 and headquartered in Tullamarine, Victoria, operating as the only GMP-accredited peptide manufacturer in Australia. The business runs on a two-tier model: a non-GMP catalogue and custom synthesis line for research customers (offering off-the-shelf peptides, amino acids, resins, reagents, and solvents alongside custom peptide libraries, purification, and analytical services) and a GMP manufacturing line operated through subsidiary Auspep Clinical Peptides Pty Ltd, which produces peptide APIs for clinical trials and commercial production. Core technology is solid phase peptide synthesis (SPPS) at scales from milligrams to kilograms, supported by in-house analytical capabilities including amino acid analysis, chromatography, NMR, mass spectroscopy, impurity profiling, and stability trials compliant with ICH and GMP standards.

The company generates revenue through quote-based one-time orders for custom peptides, GMP API contracts, and catalogue sales, plus fee-for-service analytical testing. It is TGA-registered (equivalent to FDA/EMEA) and ISO9001:2015 certified for non-GMP activities. Auspep also serves as the exclusive Australian distributor for four international principals — Bachem, Dojindo Molecular Technologies, Acris Antibodies, and Accurate Chemical — providing access to over 110,000 catalogue SKUs. The go-to-market is sales-led, direct B2B, restricted to bona fide registered research or manufacturing bodies, with stock products delivered within 2 working days and custom products within 5-25 working days via validated cold-chain logistics. Customer segments are R&D biotech, large multinational pharmaceutical companies, life science research organizations, and clinical trial sponsors requiring IND/DMF regulatory documentation support.

Short descriptiontext

Auspep is an Australian specialty manufacturer of synthetic peptides, operating as the only TGA-registered GMP peptide manufacturer in Australia. It serves pharmaceutical, biotech, and life science research customers with custom peptide synthesis, GMP API manufacturing, and analytical services, and distributes international brands domestically.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTullamarine, Australia
HQ citystring
Tullamarine
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom peptide synthesis, GMP peptide manufacturing, active pharmaceutical ingredients, solid phase peptide synthesis, peptide analytical services
Industry2 codes
1Therapeutic Peptides & Protein/Peptide Biologics
CodeHLAAAAAHPrimaryYes
2Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryNo
NAICS code3 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
SIC code3 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Peptide Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Custom Peptide Synthesis (NON-GMP)
TypeOne Time License
Description

Custom synthesis of research peptides for quantities from research up to pilot scale, with options for uncommon amino acids, modifications, and specific purity levels.

auspep.com.au
2GMP Peptide Products and Services
TypeOne Time License
Description

Manufacturing of GMP peptides as active pharmaceutical ingredients (APIs) suitable for clinical trials and commercial production. Includes documentation and regulatory support for IND/DMF filings.

auspep.com.au
3Catalogue Products
TypeOne Time License
Description

Off-the-shelf peptides, amino acids, resins, reagents, and solvents sold via catalogue.

auspep.com.au
4Analytical Services
TypeProfessional Services
Description

Fee-for-service analytical testing including amino acid analysis, chromatography, mass spectroscopy, NMR, impurity profiling, stability trials, and water content testing.

auspep.com.au
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Pricing details1 tier
1Quote-based pricing for all products and services
ModelOtherBilling cadencePay-as-you-go
Notes

Contact sales for pricing on custom peptides, GMP products, catalogue items, and analytical services. No public pricing available.

auspep.com.au
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Auspep manufactures and supplies synthetic peptides for the life science and pharmaceutical sectors, spanning non-GMP catalogue items (peptides, amino acids, resins, reagents, solvents) and custom peptide synthesis/libraries/purification, alongside TGA-registered GMP manufacturing of peptide active pharmaceutical ingredients (APIs) from clinical to commercial scale, supported by GMP-compliant analytical services and regulatory documentation support for IND and DMF filings. It also acts as the Australian distributor for international brands including Bachem, Dojindo, Acris Antibodies, and Accurate Chemical.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Peptides with impurity >0.5% are identified under GMP standards
+1 more record
Product overview1 text field

Auspep is an Australian peptide manufacturer offering two main service tiers: non-GMP research products and GMP clinical manufacturing. Non-GMP offerings include catalogue products (Peptides, Amino Acids, Resins, Reagents, Solvents) alongside custom services (Custom Peptide Synthesis, Custom Peptide Libraries, Custom Peptide Purification, Custom Analytical Services). GMP services include GMP Manufacturing for clinical and commercial scale APIs, GMP Analytical Services (amino acid analysis, chromatography, mass spectroscopy, NMR, stability trials), Compliance & Regulatory Support for IND/DMF filings, and GMP API Collaborations. Additionally, Auspep distributes complementary products through agency partnerships with Accurate Chemical (60,000+ products), Acris Antibodies (50,000+ products), Bachem (peptides and biochemicals), and Dojindo Molecular Technologies (800+ products).

Product and service17 records
1Non-GMP Catalogue Peptides
CategoryPeptide catalogue products
Description

Off-the-shelf synthetic peptides sold by gross weight, typically dispensed in glass primary packaging with a certificate of analysis, for research and life science use.

2Amino Acids
CategoryPeptide synthesis consumables
Description

Off-the-shelf amino acids for peptide synthesis and research applications.

3Resins
CategoryPeptide synthesis consumables
Description

Off-the-shelf resins for solid phase peptide synthesis.

4Reagents
CategoryPeptide synthesis consumables
Description

Off-the-shelf reagents for peptide synthesis and laboratory research.

5Solvents
CategoryPeptide synthesis consumables
Description

Off-the-shelf solvents for peptide synthesis and laboratory use.

6Custom Peptide Synthesis
CategoryCustom peptide services
Description

Custom synthesis of peptides from research scale to pilot scale with modification options including acetylation, phosphorylation, biotinylation, succinylation, cyclisation, and fluorescent labeling; includes guaranteed sequences with mass spectral and HPLC analyses.

7Custom Peptide Libraries
CategoryCustom peptide services
Description

Custom synthesis of combinatory peptide libraries supporting epitope detection and identification of peptide antagonists; supports common and uncommon amino acids, variable sequence length, quantity specifications, and final product forms (solid phase or free compound).

8Custom Peptide Purification
CategoryCustom peptide services
Description

Purification service to recover peptides from assembly impurities using HPLC-based purification methods.

9Custom Analytical Services
CategoryAnalytical services
Description

Non-GMP analytical testing including amino acid analysis, mass spectroscopy, NMR spectroscopy, and custom protein carrier conjugation for antisera production.

10GMP Manufacturing
CategoryGMP manufacturing services
Description

TGA-registered GMP peptide manufacturing from clinical scale to commercial scale using solid phase peptide synthesis, including process development and scale-up of Active Pharmaceutical Ingredients (APIs) compliant with local and international regulators.

11GMP Analytical Services
CategoryGMP analytical services
Description

GMP-compliant analytical services including amino acid analysis, analytical chromatography, impurity profiling, ion content analysis, mass spectroscopy, N-terminal protein sequencing, NMR spectroscopy, stability trials, and water content testing.

12Compliance and Regulatory Support
CategoryRegulatory affairs services
Description

Documentation preparation and regulatory support for IND and DMF filings, including Chemistry Manufacturing and Controls Information (CMCI) preparation for FDA approval.

13GMP API Collaborations
CategoryGMP collaboration services
Description

Partnership service for confidential GMP peptide development from process development through commercial production for clinical trials and proprietary projects.

14Accurate Chemical Distributed Products
CategoryDistributed brand products
Description

Australian distribution of Accurate Chemical's catalogue including antibodies, antigens, cell separation media, complements, reagents, controls, complex carbohydrates, and ligands (nearly 60,000 entries).

15Acris Antibodies Distributed Products
CategoryDistributed brand products
Description

Australian distribution of Acris Antibodies' catalogue of over 50,000 antibodies and antigens, including the Antibody Location Service for matching customer requirements.

16Bachem Distributed Products
CategoryDistributed brand products
Description

Australian distribution of Bachem's high-quality biochemical and pharmaceutical compounds, including thousands of catalogue products (peptides, biochemicals, building blocks, immunochemicals) and over 25 generic peptide APIs.

17Dojindo Molecular Technologies Distributed Products
CategoryDistributed brand products
Description

Australian distribution of over 800 Dojindo research products used by research organisations across multiple disciplines.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Auspep distributes Dojindo products in Australia. Dojindo produces over 800 well-known products used by research organisations in many disciplines, including products developed jointly between Dojindo staff and outside researchers.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Auspep distributes Bachem products in Australia. Bachem is an independent, technology-based company specializing in high quality innovative biochemical and pharmaceutical compounds, offering thousands of catalogue products including peptides, biochemicals, building blocks, and immunochemicals, as well as over 25 generic peptide APIs.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Auspep distributes Acris products in Australia. Acris offers over 50,000 products (primarily antibodies and antigens) and provides services including Antibody Location Service and newsletter.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Auspep distributes Accurate Chemical products in Australia. Founded in 1974, Accurate offers nearly 60,000 entries including antibodies, antigens, cell separation media, reagents, and represents multiple international companies.

Strategic tierMinorTypeOthers
Description

Accurate Chemical represents international companies including ALERE/AXIS SHIELD (Norway), CEDARLANE (Canada), DENKA SEIKEN CO (Japan), SANQUIN (Holland), LATOXAN (France), NOVAMED (Israel), and many others.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty peptide synthesis company offering custom peptides, libraries, and peptidomimetics for research and preclinical use. Comparable custom SPPS capability and customer base in life science research.

TypeBroad incumbent
Description

Large life sciences services company offering custom peptide synthesis alongside gene synthesis, protein production, and cell therapy services. Wider portfolio but meaningful peptide overlap.

TypeDirect peer
Description

Global market leader in peptide API manufacturing and CMO services. Direct competitor in GMP peptide manufacturing; notably Auspep already distributes Bachem products in Australia, illustrating full overlap of core capability.

TypeDirect peer
Description

Catalogue and custom research peptide supplier targeting academic and industrial research customers. Overlaps directly with Auspep's catalogue peptides and custom synthesis lines.

TypeDirect peer
Description

Peptide synthesis technology and contract manufacturer offering custom peptides, GMP manufacturing, and peptide synthesizers. Directly comparable SPPS-based service portfolio.

TypeDirect peer
Description

US-based peptide CDMO specializing in GMP peptide API manufacturing for clinical and commercial supply. Operates at comparable scale to Auspep in custom and complex peptide synthesis.

TypeDirect peer
Description

Publicly listed peptide CDMO offering custom synthesis, GMP manufacturing, and analytical services for therapeutic peptides and oligonucleotides. Directly comparable service portfolio targeting the same pharma/biotech customer base.

TypeDirect peer
Description

Global CDMO with a dedicated peptide platform spanning mg to commercial scale under GMP. Comparable end-to-end peptide API offering to pharmaceutical and biotech clients worldwide.

TypeBroad incumbent
Description

Global life sciences leader whose peptide and custom synthesis offerings (including through Patheon CDMO) compete at the higher end of the market. Provides the broad incumbent benchmark for Auspep's GMP and analytical services.

TypeDirect peer
Description

Custom peptide synthesis and antibody production services for research and clinical applications. Closely matches Auspep's research-grade and custom modification offering.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Auspep

Pharmaceutical Peptide Manufacturingauspep.com.au

Auspep is an Australian specialty manufacturer of synthetic peptides, operating as the only TGA-registered GMP peptide manufacturer in Australia. It serves pharmaceutical, biotech, and life science research customers with custom peptide synthesis, GMP API manufacturing, and analytical services, and distributes international brands domestically.

What Auspep does

Auspep is an Australian specialty manufacturer of synthetic peptides, founded in 1987 and headquartered in Tullamarine, Victoria, operating as the only GMP-accredited peptide manufacturer in Australia. The business runs on a two-tier model: a non-GMP catalogue and custom synthesis line for research customers (offering off-the-shelf peptides, amino acids, resins, reagents, and solvents alongside custom peptide libraries, purification, and analytical services) and a GMP manufacturing line operated through subsidiary Auspep Clinical Peptides Pty Ltd, which produces peptide APIs for clinical trials and commercial production. Core technology is solid phase peptide synthesis (SPPS) at scales from milligrams to kilograms, supported by in-house analytical capabilities including amino acid analysis, chromatography, NMR, mass spectroscopy, impurity profiling, and stability trials compliant with ICH and GMP standards.

The company generates revenue through quote-based one-time orders for custom peptides, GMP API contracts, and catalogue sales, plus fee-for-service analytical testing. It is TGA-registered (equivalent to FDA/EMEA) and ISO9001:2015 certified for non-GMP activities. Auspep also serves as the exclusive Australian distributor for four international principals — Bachem, Dojindo Molecular Technologies, Acris Antibodies, and Accurate Chemical — providing access to over 110,000 catalogue SKUs. The go-to-market is sales-led, direct B2B, restricted to bona fide registered research or manufacturing bodies, with stock products delivered within 2 working days and custom products within 5-25 working days via validated cold-chain logistics. Customer segments are R&D biotech, large multinational pharmaceutical companies, life science research organizations, and clinical trial sponsors requiring IND/DMF regulatory documentation support.

Auspep firmographics

Firmographics
Name
Auspep
Legal name
Auspep
Website
https://auspep.com.au
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
11–50 employees
Short description
Auspep is an Australian specialty manufacturer of synthetic peptides, operating as the only TGA-registered GMP peptide manufacturer in Australia. It serves pharmaceutical, biotech, and life science research customers with custom peptide synthesis, GMP API manufacturing, and analytical services, and distributes international brands domestically.
Ownership category
akta.pro rank

Auspep industry classification

Industry
Product category
Pharmaceutical Peptide Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)
akta.pro secondary industry
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

  • Custom peptide synthesis
  • GMP peptide manufacturing
  • Active pharmaceutical ingredients
  • Solid phase peptide synthesis
  • Peptide analytical services

Where Auspep is headquartered

Location

Headquarters

HQ city
Tullamarine
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Auspep business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Custom Peptide Synthesis (NON-GMP): Custom synthesis of research peptides for quantities from research up to pilot scale, with options for uncommon amino acids, modifications, and specific purity levels.
  2. GMP Peptide Products and Services: Manufacturing of GMP peptides as active pharmaceutical ingredients (APIs) suitable for clinical trials and commercial production. Includes documentation and regulatory support for IND/DMF filings.
  3. Catalogue Products: Off-the-shelf peptides, amino acids, resins, reagents, and solvents sold via catalogue.
  4. Analytical Services: Fee-for-service analytical testing including amino acid analysis, chromatography, mass spectroscopy, NMR, impurity profiling, stability trials, and water content testing.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based pricing for all products and services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Auspep product offering

Product offering

Core offering

Auspep manufactures and supplies synthetic peptides for the life science and pharmaceutical sectors, spanning non-GMP catalogue items (peptides, amino acids, resins, reagents, solvents) and custom peptide synthesis/libraries/purification, alongside TGA-registered GMP manufacturing of peptide active pharmaceutical ingredients (APIs) from clinical to commercial scale, supported by GMP-compliant analytical services and regulatory documentation support for IND and DMF filings. It also acts as the Australian distributor for international brands including Bachem, Dojindo, Acris Antibodies, and Accurate Chemical.

Product overview

Auspep is an Australian peptide manufacturer offering two main service tiers: non-GMP research products and GMP clinical manufacturing. Non-GMP offerings include catalogue products (Peptides, Amino Acids, Resins, Reagents, Solvents) alongside custom services (Custom Peptide Synthesis, Custom Peptide Libraries, Custom Peptide Purification, Custom Analytical Services). GMP services include GMP Manufacturing for clinical and commercial scale APIs, GMP Analytical Services (amino acid analysis, chromatography, mass spectroscopy, NMR, stability trials), Compliance & Regulatory Support for IND/DMF filings, and GMP API Collaborations. Additionally, Auspep distributes complementary products through agency partnerships with Accurate Chemical (60,000+ products), Acris Antibodies (50,000+ products), Bachem (peptides and biochemicals), and Dojindo Molecular Technologies (800+ products).

Differentiator

Problem solved

Functional benefit

Products and services

  • Non-GMP Catalogue Peptides Off-the-shelf synthetic peptides sold by gross weight, typically dispensed in glass primary packaging with a certificate of analysis, for research and life science use.
  • Amino Acids Off-the-shelf amino acids for peptide synthesis and research applications.
  • Resins Off-the-shelf resins for solid phase peptide synthesis.
  • Reagents Off-the-shelf reagents for peptide synthesis and laboratory research.
  • Solvents Off-the-shelf solvents for peptide synthesis and laboratory use.
  • Custom Peptide Synthesis Custom synthesis of peptides from research scale to pilot scale with modification options including acetylation, phosphorylation, biotinylation, succinylation, cyclisation, and fluorescent labeling; includes guaranteed sequences with mass spectral and HPLC analyses.
  • Custom Peptide Libraries Custom synthesis of combinatory peptide libraries supporting epitope detection and identification of peptide antagonists; supports common and uncommon amino acids, variable sequence length, quantity specifications, and final product forms (solid phase or free compound).
  • Custom Peptide Purification Purification service to recover peptides from assembly impurities using HPLC-based purification methods.
  • Custom Analytical Services Non-GMP analytical testing including amino acid analysis, mass spectroscopy, NMR spectroscopy, and custom protein carrier conjugation for antisera production.
  • GMP Manufacturing TGA-registered GMP peptide manufacturing from clinical scale to commercial scale using solid phase peptide synthesis, including process development and scale-up of Active Pharmaceutical Ingredients (APIs) compliant with local and international regulators.
  • GMP Analytical Services GMP-compliant analytical services including amino acid analysis, analytical chromatography, impurity profiling, ion content analysis, mass spectroscopy, N-terminal protein sequencing, NMR spectroscopy, stability trials, and water content testing.
  • Compliance and Regulatory Support Documentation preparation and regulatory support for IND and DMF filings, including Chemistry Manufacturing and Controls Information (CMCI) preparation for FDA approval.
  • GMP API Collaborations Partnership service for confidential GMP peptide development from process development through commercial production for clinical trials and proprietary projects.
  • Accurate Chemical Distributed Products Australian distribution of Accurate Chemical's catalogue including antibodies, antigens, cell separation media, complements, reagents, controls, complex carbohydrates, and ligands (nearly 60,000 entries).
  • Acris Antibodies Distributed Products Australian distribution of Acris Antibodies' catalogue of over 50,000 antibodies and antigens, including the Antibody Location Service for matching customer requirements.
  • Bachem Distributed Products Australian distribution of Bachem's high-quality biochemical and pharmaceutical compounds, including thousands of catalogue products (peptides, biochemicals, building blocks, immunochemicals) and over 25 generic peptide APIs.
  • Dojindo Molecular Technologies Distributed Products Australian distribution of over 800 Dojindo research products used by research organisations across multiple disciplines.

Quantifiable outcome

  • Peptides with impurity >0.5% are identified under GMP standards
  • +1 more outcomes

Companies that use Auspep

Customer profile

Segments3 records

Ideal customer profiles2 records

Auspep technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Auspep partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor.

  • Dojindo Molecular TechnologiesminorChannel Partner/ Reseller/ DistributorAuspep distributes Dojindo products in Australia. Dojindo produces over 800 well-known products used by research organisations in many disciplines, including products developed jointly between Dojindo staff and outside researchers.
  • BachemminorChannel Partner/ Reseller/ DistributorAuspep distributes Bachem products in Australia. Bachem is an independent, technology-based company specializing in high quality innovative biochemical and pharmaceutical compounds, offering thousands of catalogue products including peptides, biochemicals, building blocks, and immunochemicals, as well as over 25 generic peptide APIs.
  • Acris AntibodiesminorChannel Partner/ Reseller/ DistributorAuspep distributes Acris products in Australia. Acris offers over 50,000 products (primarily antibodies and antigens) and provides services including Antibody Location Service and newsletter.
  • Accurate Chemical & Scientific CorporationminorChannel Partner/ Reseller/ DistributorAuspep distributes Accurate Chemical products in Australia. Founded in 1974, Accurate offers nearly 60,000 entries including antibodies, antigens, cell separation media, reagents, and represents multiple international companies.
  • Accurate Chemical International PartnersminorOthersAccurate Chemical represents international companies including ALERE/AXIS SHIELD (Norway), CEDARLANE (Canada), DENKA SEIKEN CO (Japan), SANQUIN (Holland), LATOXAN (France), NOVAMED (Israel), and many others.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Auspep competitors and assessment

Company assessment

Direct peers

  • AAPPTec: Specialty peptide synthesis company offering custom peptides, libraries, and peptidomimetics for research and preclinical use. Comparable custom SPPS capability and customer base in life science research.
  • Bachem: Global market leader in peptide API manufacturing and CMO services. Direct competitor in GMP peptide manufacturing; notably Auspep already distributes Bachem products in Australia, illustrating full overlap of core capability.
  • Peptide Sciences: Catalogue and custom research peptide supplier targeting academic and industrial research customers. Overlaps directly with Auspep's catalogue peptides and custom synthesis lines.
  • CSBio: Peptide synthesis technology and contract manufacturer offering custom peptides, GMP manufacturing, and peptide synthesizers. Directly comparable SPPS-based service portfolio.
  • AmbioPharm: US-based peptide CDMO specializing in GMP peptide API manufacturing for clinical and commercial supply. Operates at comparable scale to Auspep in custom and complex peptide synthesis.
  • PolyPeptide Group: Publicly listed peptide CDMO offering custom synthesis, GMP manufacturing, and analytical services for therapeutic peptides and oligonucleotides. Directly comparable service portfolio targeting the same pharma/biotech customer base.
  • CordenPharma: Global CDMO with a dedicated peptide platform spanning mg to commercial scale under GMP. Comparable end-to-end peptide API offering to pharmaceutical and biotech clients worldwide.
  • Bio-Synthesis Inc: Custom peptide synthesis and antibody production services for research and clinical applications. Closely matches Auspep's research-grade and custom modification offering.

Broad incumbents

  • GenScript: Large life sciences services company offering custom peptide synthesis alongside gene synthesis, protein production, and cell therapy services. Wider portfolio but meaningful peptide overlap.
  • Thermo Fisher Scientific: Global life sciences leader whose peptide and custom synthesis offerings (including through Patheon CDMO) compete at the higher end of the market. Provides the broad incumbent benchmark for Auspep's GMP and analytical services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Auspep social profiles

Digital presence

Auspep compliance and trust

Trust signal

Compliance2 records

Auspep financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Auspep leadership team

Management profile

Number of profiles

Profiles1 record

Auspep subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Auspep funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Auspep M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Auspep

What does Auspep do?

Auspep manufactures and supplies synthetic peptides for the life science and pharmaceutical sectors, spanning non-GMP catalogue items (peptides, amino acids, resins, reagents, solvents) and custom peptide synthesis/libraries/purification, alongside TGA-registered GMP manufacturing of peptide active pharmaceutical ingredients (APIs) from clinical to commercial scale, supported by GMP-compliant analytical services and regulatory documentation support for IND and DMF filings. It also acts as the Australian distributor for international brands including Bachem, Dojindo, Acris Antibodies, and Accurate Chemical.

Is Auspep a public or private company?

Auspep is a private company. It is classified as unknown and is currently operating.

When was Auspep founded?

Auspep was founded in 1987. It employs 11 to 50 people.

Where is Auspep based?

Auspep is headquartered in Tullamarine, Australia, in the Oceania region.

How does Auspep make money?

Four revenue lines are on record. Custom Peptide Synthesis (NON-GMP) is the primary driver. The others are GMP Peptide Products and Services, catalogue Products and analytical Services.

Who are Auspep's main competitors?

Direct peers on record are AAPPTec, Bachem, Peptide Sciences, CSBio, AmbioPharm, PolyPeptide Group, CordenPharma and Bio-Synthesis Inc. Broad incumbents are GenScript and Thermo Fisher Scientific.

Does Auspep have an API?

No public API is recorded for Auspep.

What industry is Auspep in?

Auspep's product category is Pharmaceutical Peptide Manufacturing. Its primary akta.pro industry code is HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics, with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales